Overview of Hormonal IUD Products Approved by a Stringent Regulatory Authority and Available in Low-Income Countriesa
| Supplier | Quality-Assured Hormonal IUD Product Containing 52 mg LNG |
|---|---|
| Bayer AGb | Mirena |
| International Contraceptive Access Foundation | Unbranded LNG IUS product |
| Medicines360 | Avibelac |
Abbreviation: IUD, intrauterine device; LNG, levonorgestrel; SRA, stringent regulatory authority.
↵a In addition to the products listed in the table, several hormonal IUD products are being introduced in a limited number of FP2020/FP2030 countries that are not currently approved by an SRA. In 2022, Mirena was the first hormonal IUD product to be prequalified by the World Health Organization.
↵b Bayer AG also manufactures the lower-dose hormonal IUD products Skyla and Kyleena. However, these products are not yet available in low- and middle-income countries, and therefore are not discussed in this paper.
↵c The Medicines360 product is sold in the United States under trade name Liletta; the product is sold in FP2020/FP2030 countries under the trade name Avibela.